$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is it necessary to undergo genetic testing and analysis before using Tepotinib (Tuodekang)?
2026-02-01 22:25:32
Check Details
Analysis of the best time to take Regorafenib (Belvango) and daily medication precautions
2026-02-01 22:25:32
Check Details
A must-read guide for patients with contraindications and precautions for using Pazopanib (Victor)
2026-02-01 22:25:32
Check Details
Opicapone original manufacturer information and drug background introduction
2026-02-01 22:25:32
Check Details
Fenelidone (Keshenda) toxicity intensity analysis and safe dose reference
2026-02-01 22:25:32
Check Details
Analysis of the range of diseases and indications that rasagiline (Azilai) can treat
2026-02-01 22:25:32
Check Details
Introduction and R&D background of Trelagliptin produced by Takeda Pharmaceuticals in Japan
2026-02-01 22:25:32
Check Details
The official launch time and domestic approval progress of Inalise (Ihelai)
2026-02-01 22:25:32
Check Details
What diseases does Abatacept (Enrisu) mainly treat and its clinical scope of application?
2026-02-01 22:25:32
Check Details
A complete list of precautions and medication contraindications during the use of Lebolaysin (Davico)
2026-02-01 22:25:32
Check Details
Analysis of real patient use effects and clinical trial data of Mavakatai (Mefanto)
2026-02-01 22:25:32
Check Details
Possible side effects after discontinuation of tenofovir alafenamide fumarate tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
1
2
...
1961
1962
1963
1964
1965
1966
1967
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma